Global Hormone Replacement Therapy Market 2015-2019 - Leading Vendors are F. Hoffmann-La Roche, Merck Serono, Novartis, Novo Nordisk, and Pfizer

Dec 02, 2015, 03:30 ET from Research and Markets

DUBLIN, December 2, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/xf2xrg/global_hormone) has announced the addition of the "Global Hormone Replacement Therapy Market 2015-2019" report to their offering.  

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
 

The report presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market, including F. Hoffmann-La Roche, Merck Serono, Novartis, Novo Nordisk, and Pfizer.

Hormone replacement therapy involves the replacement of the hormones in the body whose levels have become low, in case of women nearing menopause or patient with growth hormone deficiency due to conditions such as dwarfism. At present, the combination of drugs are used to treat the conditions, which are known to have a better safety and efficacy parameter. Unmet medical needs is one of the major drivers influencing the growth of the market. Therefore, the need for new treatment options with better safety results to accommodate the current unmet need is huge.

In 2014, the Americas dominated the market, where the majority of the contribution was from the US, and this trend is expected to continue during the forecast period. However, the market in the APAC region is witnessing a rapid growth, hence, there is a vast opportunity for vendors to venture into this region. Technavio expects the global hormone replacement therapy market to grow at a moderate rate, posting a CAGR of over 2% during the forecast period.

With a market share of more than 60% the estrogen replacement therapy segment dominate the hormone replacement therapy market. Estrogen replacement therapy is a type of therapy in which estrogen hormones are commonly used to treat the symptoms of menopause. It helps in the reduction of short-term changes of menopause such as hot flashes, disturbed sleep, and vaginal dryness.

Segmentation of the hormone replacement therapy market by route of administration

- Oral
- Parenteral
- Transdermal

Key questions answered in the report include

- What will the market size and the growth rate be in 2019?
- What are the key factors driving the global hormone replacement therapy market?
- What are the Key Market trends?impacting the growth of the global hormone replacement therapy market? 
- What are the challenges to market growth?
- Who are the key vendors in the global hormone replacement therapy market?
- What are the market opportunities and threats faced by the vendors in the global hormone replacement therapy market?
- What are the trending factors influencing the market shares of the Americas, EMEA, and APAC?
- What are the key outcomes of the five forces analysis of the global hormone replacement therapy market? 

For more information visit http://www.researchandmarkets.com/research/xf2xrg/global_hormone

About Research and Markets: 

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Media Contact: 
Laura Wood
+353-1-481-1716
press@researchandmarkets.net


SOURCE Research and Markets